Johnson & Johnson
JNJ
$151.82
Share price
-0.97%
Change (1 day)
-14.63%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Number of shares outstanding for Johnson & Johnson (JNJ)
Number of shares outstanding as of March 2023 : 2,627,900,000
According to Johnson & Johnson's latest financial reports and stock price the company's current number of shares outstanding is 2,627,900,000. At the end of 2022 the company had 2,627,900,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Johnson & Johnson from 2001 to 2022
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2022 | 2.62 B | -0.04% |
| 2021 | 2.62 B | -0.13% |
| 2020 | 2.63 B | |
| 2019 | 2.63 B | -3.36% |
| 2018 | 2.72 B | 1.46% |
| 2017 | 2.68 B | -0.8% |
| 2016 | 2.70 B | -1.77% |
| 2015 | 2.75 B | -1.01% |
| 2014 | 2.78 B | -1.33% |
| 2013 | 2.82 B | 1.52% |
| 2012 | 2.77 B | 1.69% |
| 2011 | 2.73 B | -0.56% |
| 2010 | 2.74 B | -1.62% |
| 2009 | 2.79 B | 0.08% |
| 2008 | 2.79 B | -3.35% |
| 2007 | 2.88 B | -1.11% |
| 2006 | 2.92 B | -1.84% |
| 2005 | 2.97 B | 0.22% |
| 2004 | 2.96 B | |
| 2003 | 2.96 B | -0.22% |
| 2002 | 2.97 B | -2.13% |
| 2001 | 3.03 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 2,167,000,000 | -17.54% | 🇨🇭 Switzerland |
 Pfizer PFE | 5,607,000,000 | 113.36% | 🇺🇸 USA |
 Abbott Laboratories ABT | 1,737,795,021 | -33.87% | 🇺🇸 USA |
 Medtronic MDT | 1,330,200,000 | -49.38% | 🇮🇪 Ireland |
 Eli Lilly LLY | 950,182,000 | -63.84% | 🇺🇸 USA |
 Sanofi SNY | 2,507,000,000 | -4.60% | 🇫🇷 France |
 Gilead Sciences GILD | 1,255,000,000 | -52.24% | 🇺🇸 USA |
 Stryker Corporation SYK | 378,400,000 | -85.60% | 🇺🇸 USA |
 Merck MRK | 2,533,000,000 | -3.61% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,017,000,000 | -23.25% | 🇬🇧 UK |